Filed before 2025Filed 19 April 2022
Triana Biomedicines, Inc. has sold $42.6M so far
Triana Biomedicines, Inc., a pharmaceuticals company based in Waltham, MA, has sold $42.6M so far in its equity round, according to a filing dated 19 April 2022.
Raises filed before 2025 are not checked for a public announcement.
- Filed
- 19 April 2022
- First filed
- 11 February 2022
- Round
- Equity round (amended filing)
- Amount sold
- $42.6M
- Offering size
- $85.1M
- Investors so far
- 14
- Based in
- Waltham, MA
- Website
- trianabio.com
Investors on the board
Firms come from the venture funds whose filings name a director of this company.
Who is on the board
4 directors of this company are named on venture funds' filings. Sign in free with Google to see who, the full filing, and a short list of rounds like this each morning.
Sign in with GoogleHow it compares
Larger than 85% of the 1,764 tracked raises with an amount filed in 2022, and than 84% of the 38 in pharmaceuticals.
Triana Biomedicines, Inc. in public filings
| Filed | Filing | Sold | Raise |
|---|---|---|---|
| 4 Dec 2025 | New filing | $120M | Another raise |
| 19 Apr 2022 | Amended filing | $42.6M | This raise |
| 11 Feb 2022 | New filing | $34.8M | This raise |
| 17 Sep 2021 | New filing | $10M | Another raise |
| 6 Jul 2020 | New filing | $6M | Another raise |
More with Atlas on the board
Other unannounced rounds
- DVx Atomic Co.$18.5M
- Aperio Systems, Inc.$1.6M
- Twin Health, Inc.$59M
- Scoring Factory AI Inc.$500K
- Royal & Pelham, Inc.$5.4M
- SPECTRA Holdings US, Ltd.$2.5M
Seen it announced?
Send the link and the check will look at it.